pediatric-vaccines
(2)
Canid
Canid is a New York-based health technology company that turns the messy, expensive job of running a pediatric vaccine program into a simple scan-and-go workflow. Its platform plugs directly into a practice's electronic health record and handles vaccine purchasing, inventory, insurance billing, VFC compliance, registry reporting, and patient outreach - the administrative and financial weight that causes most pediatric offices to break even or lose money on vaccines. The pitch is blunt: you give vaccines, Canid does everything else.
Pedro Sanchez de Lozada
Pedro Sanchez de Lozada is the founder and CEO of Canid, a New York healthtech company that takes the operational, financial, and data drudgery of running a vaccine program off pediatricians' plates. A Chilean who has spent more than 15 years building software for small businesses (Udemy, Rinse, Merlin), he started Canid in 2020 after managing his pediatrician relatives' practices during the Covid-19 pandemic. In 2025 Canid raised a $10M Series A led by Telescope Partners, bringing total funding to $12.9M, while serving 150+ independent pediatricians across 12 states.